Latest Insider Transactions at Natera, Inc. (NTRA)
This section provides a real-time view of insider transactions for Natera, Inc. (NTRA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Natera, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Natera, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 29
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,235
-3.36%
|
$210,275
$65.09 P/Share
|
|
Jan 29
2024
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
14,813
-5.66%
|
$962,845
$65.09 P/Share
|
|
Jan 29
2024
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,265
-2.05%
|
$277,225
$65.09 P/Share
|
|
Jan 29
2024
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
546
-0.11%
|
$35,490
$65.09 P/Share
|
|
Jan 29
2024
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct |
3,426
-1.73%
|
$222,690
$65.09 P/Share
|
|
Jan 29
2024
|
John Fesko PRESIDENT, CHIEF BUS. OFFICER |
SELL
Open market or private sale
|
Direct |
2,358
-2.13%
|
$153,270
$65.09 P/Share
|
|
Jan 26
2024
|
Matthew Rabinowitz EXECUTIVE CHAIRMAN |
BUY
Grant, award, or other acquisition
|
Direct |
68,976
+6.04%
|
-
|
|
Jan 26
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
31,352
+24.59%
|
-
|
|
Jan 26
2024
|
Steven Leonard Chapman CEO AND PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
86,220
+24.78%
|
-
|
|
Jan 26
2024
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
27,433
+11.63%
|
-
|
|
Jan 26
2024
|
Jonathan Sheena |
BUY
Grant, award, or other acquisition
|
Direct |
9,405
+1.93%
|
-
|
|
Jan 26
2024
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
BUY
Grant, award, or other acquisition
|
Direct |
31,352
+13.65%
|
-
|
|
Jan 26
2024
|
John Fesko PRESIDENT, CHIEF BUS. OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
31,352
+22.05%
|
-
|
|
Jan 26
2024
|
Roy D. Baynes |
BUY
Grant, award, or other acquisition
|
Direct |
215
+1.7%
|
$13,545
$63.79 P/Share
|
|
Jan 26
2024
|
Roelof Botha |
BUY
Grant, award, or other acquisition
|
Direct |
352
+50.0%
|
$22,176
$63.79 P/Share
|
|
Jan 26
2024
|
James Healy |
BUY
Grant, award, or other acquisition
|
Direct |
264
+0.62%
|
$16,632
$63.79 P/Share
|
|
Jan 26
2024
|
Herm Rosenman |
BUY
Grant, award, or other acquisition
|
Direct |
303
+0.49%
|
$19,089
$63.79 P/Share
|
|
Jan 24
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
944
-1.44%
|
$63,248
$67.0 P/Share
|
|
Jan 23
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,202
-1.63%
|
$145,332
$66.25 P/Share
|
|
Jan 22
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
771
-1.12%
|
$52,428
$68.16 P/Share
|
|
Jan 22
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+1.79%
|
-
|
|
Jan 22
2024
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
892
-0.49%
|
$60,656
$68.16 P/Share
|
|
Jan 22
2024
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
1,958
-1.1%
|
$133,144
$68.16 P/Share
|
|
Jan 22
2024
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
351
-0.04%
|
$23,868
$68.16 P/Share
|
|
Jan 21
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,145
+1.67%
|
-
|
|
Jan 21
2024
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
644
+0.35%
|
-
|
|
Jan 21
2024
|
Steven Leonard Chapman CEO AND PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct |
1,774
+0.99%
|
-
|
|
Jan 21
2024
|
Jonathan Sheena |
BUY
Exercise of conversion of derivative security
|
Direct |
143
+0.03%
|
-
|
|
Jan 20
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,522
+2.24%
|
-
|
|
Jan 20
2024
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
856
+0.47%
|
-
|
|
Jan 20
2024
|
Steven Leonard Chapman CEO AND PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct |
3,386
+1.89%
|
-
|
|
Jan 20
2024
|
Jonathan Sheena |
BUY
Exercise of conversion of derivative security
|
Direct |
191
+0.04%
|
-
|
|
Jan 03
2024
|
Jonathan Sheena |
SELL
Open market or private sale
|
Indirect |
1,000
-1.54%
|
$60,000
$60.59 P/Share
|
|
Jan 03
2024
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
5,000
-0.53%
|
$300,000
$60.32 P/Share
|
|
Dec 29
2023
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,377
-2.08%
|
$85,374
$62.29 P/Share
|
|
Dec 28
2023
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
915
-1.36%
|
$57,645
$63.29 P/Share
|
|
Dec 28
2023
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
2,604
-1.49%
|
$164,052
$63.29 P/Share
|
|
Dec 28
2023
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
728
-0.4%
|
$45,864
$63.29 P/Share
|
|
Dec 28
2023
|
Jonathan Sheena |
SELL
Open market or private sale
|
Indirect |
1,000
-2.26%
|
$62,000
$62.12 P/Share
|
|
Dec 28
2023
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
447
-0.05%
|
$27,714
$62.68 P/Share
|
|
Dec 27
2023
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,292
+3.3%
|
-
|
|
Dec 27
2023
|
Steven Leonard Chapman CEO AND PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct |
5,183
+2.88%
|
-
|
|
Dec 27
2023
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,363
+0.75%
|
-
|
|
Dec 27
2023
|
Jonathan Sheena |
BUY
Exercise of conversion of derivative security
|
Direct |
447
+0.09%
|
-
|
|
Dec 13
2023
|
James Healy |
SELL
Open market or private sale
|
Indirect |
644,000
-100.0%
|
$37,352,000
$58.75 P/Share
|
|
Dec 12
2023
|
Matthew Rabinowitz EXECUTIVE CHAIRMAN |
SELL
Bona fide gift
|
Direct |
250,000
-19.94%
|
-
|
|
Dec 12
2023
|
Matthew Rabinowitz EXECUTIVE CHAIRMAN |
BUY
Bona fide gift
|
Indirect |
250,000
+27.17%
|
-
|
|
Dec 08
2023
|
Gail Boxer Marcus |
SELL
Open market or private sale
|
Direct |
500
-2.42%
|
$28,500
$57.52 P/Share
|
|
Dec 06
2023
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
5,000
-0.52%
|
$290,000
$58.52 P/Share
|
|
Nov 29
2023
|
Rowan E Chapman |
SELL
Open market or private sale
|
Direct |
1,998
-17.57%
|
$109,890
$55.97 P/Share
|